chr5-146590096-C-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_181675.4(PPP2R2B):c.1183G>T(p.Val395Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000737 in 1,614,180 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. V395V) has been classified as Likely benign.
Frequency
Consequence
NM_181675.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PPP2R2B | NM_181675.4 | c.1183G>T | p.Val395Leu | missense_variant | 10/10 | ENST00000394411.9 | |
CTB-99A3.1 | XR_007058986.1 | n.229-16873C>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PPP2R2B | ENST00000394411.9 | c.1183G>T | p.Val395Leu | missense_variant | 10/10 | 2 | NM_181675.4 | P3 | |
ENST00000512730.1 | n.247-16873C>A | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 251166Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135732
GnomAD4 exome AF: 0.0000650 AC: 95AN: 1461884Hom.: 0 Cov.: 31 AF XY: 0.0000564 AC XY: 41AN XY: 727242
GnomAD4 genome AF: 0.000158 AC: 24AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74466
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2022 | The c.1192G>T (p.V398L) alteration is located in exon 9 (coding exon 9) of the PPP2R2B gene. This alteration results from a G to T substitution at nucleotide position 1192, causing the valine (V) at amino acid position 398 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at